Leo Feferman

694 total citations
30 papers, 495 citations indexed

About

Leo Feferman is a scholar working on Molecular Biology, Cell Biology and Cancer Research. According to data from OpenAlex, Leo Feferman has authored 30 papers receiving a total of 495 indexed citations (citations by other indexed papers that have themselves been cited), including 17 papers in Molecular Biology, 14 papers in Cell Biology and 7 papers in Cancer Research. Recurrent topics in Leo Feferman's work include Proteoglycans and glycosaminoglycans research (14 papers), Glycosylation and Glycoproteins Research (10 papers) and Protein Hydrolysis and Bioactive Peptides (5 papers). Leo Feferman is often cited by papers focused on Proteoglycans and glycosaminoglycans research (14 papers), Glycosylation and Glycoproteins Research (10 papers) and Protein Hydrolysis and Bioactive Peptides (5 papers). Leo Feferman collaborates with scholars based in United States, United Kingdom and Canada. Leo Feferman's co-authors include Sumit Bhattacharyya, Joanne K. Tobacman, Krista A Varady, Hui Xie, Allan G. Halline, Stephen B. Hanauer, Jay L. Goldstein, Terry G. Unterman, Kaoru Terai and Arkadiusz Z. Dudek and has published in prestigious journals such as Journal of Biological Chemistry, SHILAP Revista de lepidopterología and Gastroenterology.

In The Last Decade

Leo Feferman

29 papers receiving 489 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Leo Feferman United States	15	227	120	82	71	69	30	495
Juan Yang China	17	334 1.5×	69 0.6×	30 0.4×	26 0.4×	78 1.1×	52	631
Denis Khnykin Norway	15	315 1.4×	165 1.4×	47 0.6×	51 0.7×	16 0.2×	26	660
Paola Traina Italy	11	119 0.5×	193 1.6×	22 0.3×	17 0.2×	28 0.4×	11	395
Ana Madeira Portugal	14	493 2.2×	49 0.4×	111 1.4×	64 0.9×	5 0.1×	24	727
Bei‐En Chang Taiwan	14	331 1.5×	92 0.8×	22 0.3×	69 1.0×	30 0.4×	21	568
Haiyan Lu United States	7	300 1.3×	60 0.5×	83 1.0×	26 0.4×	26 0.4×	7	544
Gaurav Verma India	10	246 1.1×	90 0.8×	27 0.3×	25 0.4×	13 0.2×	16	463
Boubacar Mariko France	7	104 0.5×	46 0.4×	22 0.3×	108 1.5×	51 0.7×	9	325
Chandra Sekhar Ravuri Norway	9	123 0.5×	26 0.2×	40 0.5×	30 0.4×	67 1.0×	12	374

Countries citing papers authored by Leo Feferman

Since Specialization

Citations

This map shows the geographic impact of Leo Feferman's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Leo Feferman with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Leo Feferman more than expected).

Fields of papers citing papers by Leo Feferman

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Leo Feferman. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Leo Feferman. The network helps show where Leo Feferman may publish in the future.

Co-authorship network of co-authors of Leo Feferman

This figure shows the co-authorship network connecting the top 25 collaborators of Leo Feferman. A scholar is included among the top collaborators of Leo Feferman based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Leo Feferman. Leo Feferman is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Chlipala, George E., Leo Feferman, Stefan J. Green, et al.. (2022). Nasal Dysbiosis in Cutaneous T-Cell Lymphoma Is Characterized by Shifts in Relative Abundances of Non-Staphylococcus Bacteria. SHILAP Revista de lepidopterología. 2(5). 100132–100132. 8 indexed citations

Bhattacharyya, Sumit, Leo Feferman, Xiaorui Han, et al.. (2020). Increased CHST15 follows decline in arylsulfatase B (ARSB) and disinhibition of non-canonical WNT signaling: potential impact on epithelial and mesenchymal identity. Oncotarget. 11(24). 2327–2344. 10 indexed citations

Feferman, Leo, et al.. (2020). Carrageenan-Free Diet Shows Improved Glucose Tolerance and Insulin Signaling in Prediabetes: A Randomized, Pilot Clinical Trial. Journal of Diabetes Research. 2020. 1–16. 23 indexed citations

Tobacman, Joanne K., Sumit Bhattacharyya, & Leo Feferman. (2020). Abstract 4699: Decline in Arylsulfatase B (ARSB) increases PD-L1 expression in melanoma, hepatic, prostate, and mononuclear cells. Cancer Research. 80(16_Supplement). 4699–4699. 1 indexed citations

Bhattacharyya, Sumit, Leo Feferman, & Joanne K. Tobacman. (2019). Distinct Effects of Carrageenan and High-Fat Consumption on the Mechanisms of Insulin Resistance in Nonobese and Obese Models of Type 2 Diabetes. Journal of Diabetes Research. 2019. 1–14. 15 indexed citations

Bhattacharyya, Sumit, Leo Feferman, Xiaorui Han, et al.. (2018). Decline in arylsulfatase B expression increases EGFR expression by inhibiting the protein-tyrosine phosphatase SHP2 and activating JNK in prostate cells. Journal of Biological Chemistry. 293(28). 11076–11087. 20 indexed citations

Bhattacharyya, Sumit, Leo Feferman, Girish Sharma, & Joanne K. Tobacman. (2018). Increased GPNMB, phospho-ERK1/2, and MMP-9 in cystic fibrosis in association with reduced arylsulfatase B. Molecular Genetics and Metabolism. 124(2). 168–175. 9 indexed citations

Bhattacharyya, Sumit, Hui Xie, Krista A Varady, et al.. (2017). A randomized trial of the effects of the no-carrageenan diet on ulcerative colitis disease activity. PubMed. 4(2). 181–192. 100 indexed citations

Bhattacharyya, Sumit, Leo Feferman, & Joanne K. Tobacman. (2017). Chondroitin sulfatases differentially regulate Wnt signaling in prostate stem cells through effects on SHP2, phospho-ERK1/2, and Dickkopf Wnt signaling pathway inhibitor (DKK3). Oncotarget. 8(59). 100242–100260. 18 indexed citations

10.

Bhattacharyya, Sumit, Leo Feferman, & Joanne K. Tobacman. (2016). Inhibition of Phosphatase Activity Follows Decline in Sulfatase Activity and Leads to Transcriptional Effects through Sustained Phosphorylation of Transcription Factor MITF. PLoS ONE. 11(4). e0153463–e0153463. 22 indexed citations

11.

Bhattacharyya, Sumit, Leo Feferman, & Joanne K. Tobacman. (2016). Restriction of Aerobic Metabolism by Acquired or Innate Arylsulfatase B Deficiency: A New Approach to the Warburg Effect. Scientific Reports. 6(1). 32885–32885. 14 indexed citations

12.

Bhattacharyya, Sumit, Hui Xie, Leo Feferman, et al.. (2016). Mo1792 Effects of the No Carrageenan Diet on Ulcerative Colitis Disease Activity: A Pilot and Feasibility Study. Gastroenterology. 150(4). S777–S777. 2 indexed citations

13.

Bhattacharyya, Sumit, Leo Feferman, Kaoru Terai, Arkadiusz Z. Dudek, & Joanne K. Tobacman. (2016). Decline in arylsulfatase B leads to increased invasiveness of melanoma cells. Oncotarget. 8(3). 4169–4180. 18 indexed citations

14.

Bhattacharyya, Sumit, Leo Feferman, & Joanne K. Tobacman. (2015). Carrageenan Inhibits Insulin Signaling through GRB10-mediated Decrease in Tyr(P)-IRS1 and through Inflammation-induced Increase in Ser(P)307-IRS1. Journal of Biological Chemistry. 290(17). 10764–10774. 41 indexed citations

15.

Bhattacharyya, Sumit, Leo Feferman, & Joanne K. Tobacman. (2015). Effect of CFTR modifiers on arylsulfatase B activity in cystic fibrosis and normal human bronchial epithelial cells. Pulmonary Pharmacology & Therapeutics. 36. 22–30. 6 indexed citations

16.

Bhattacharyya, Sumit, Leo Feferman, & Joanne K. Tobacman. (2014). Regulation of chondroitin-4-sulfotransferase (CHST11) expression by opposing effects of arylsulfatase B on BMP4 and Wnt9A. Biochimica et Biophysica Acta (BBA) - Gene Regulatory Mechanisms. 1849(3). 342–352. 17 indexed citations

17.

Feferman, Leo, Sumit Bhattacharyya, Lynn Birch, Gail S. Prins, & Joanne K. Tobacman. (2014). Differential effects of estrogen exposure on arylsulfatase B, galactose-6-sulfatase, and steroid sulfatase in rat prostate development. The Journal of Steroid Biochemistry and Molecular Biology. 143. 105–114. 7 indexed citations

18.

Bhattacharyya, Sumit, Leo Feferman, & Joanne K. Tobacman. (2014). Increased Expression of Colonic Wnt9A through Sp1-mediated Transcriptional Effects involving Arylsulfatase B, Chondroitin 4-Sulfate, and Galectin-3. Journal of Biological Chemistry. 289(25). 17564–17575. 27 indexed citations

19.

Bhattacharyya, Sumit, Leo Feferman, & Joanne K. Tobacman. (2013). Arylsulfatase B regulates versican expression by galectin-3 and AP-1 mediated transcriptional effects. Oncogene. 33(47). 5467–5476. 31 indexed citations

20.

Feferman, Leo, Sumit Bhattacharyya, Ryan Deaton, et al.. (2013). Arylsulfatase B (N-acetylgalactosamine-4-sulfatase): potential role as a biomarker in prostate cancer. Prostate Cancer and Prostatic Diseases. 16(3). 277–284. 24 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact